ALS Unfiltered 2018 Webinar: Important & Currently Enrolling ALS Clinical Trials

Thank you for your interest in viewing the ALS Unfiltered 2018 Webinar: Important & Currently Enrolling ALS Clinical Trials webinar!

September 25, 2018

The goal of our webinars is to provide direct answers to people with ALS, their families and others involved or interested in research leading to the development of effective treatments and cures for ALS.

This session will review the three Phase 3 trials enrolling people with ALS in the US/EU right now: NurOwn, levosimendan, and arimoclomol as well as major Phase 2 trials, such as reldesemtiv.

Please provide the following information so we can continue to make our Webinars relevant for the entire ALS community

* = Required Fields

First Name: *

Last Name: *

Email: *

Confirm Email: *

Phone: *

I Am (Relation to ALS): *